Taj Medico is a globally expanding pharmaceutical manufacturer based in India, committed to supplying high-quality generic medicines for regulated and semi-regulated markets. With advanced manufacturing infrastructure, WHO-GMP certified production facilities, and expanding EU compliance capabilities, Taj Medico supports pharmaceutical distributors, marketing authorization holders, importers, and institutional buyers worldwide.

Our regulatory team provides complete support for:

  • EU-ready dossiers
  • CTD/eCTD documentation
  • Product registration support
  • Bioequivalence documentation
  • Private labeling
  • Contract manufacturing
  • Marketing authorization partnerships

Taj Medico continues strengthening its position in Europe by offering a growing portfolio of approved and ready-to-register pharmaceutical products.


Manufacturing Capabilities

Taj Medico operates modern pharmaceutical manufacturing facilities equipped with advanced technology for high-volume production.

Monthly Production Capacity

Dosage FormCapacity
Tablets120 Million Units
Capsules40 Million Units
Oral Sachets60 Million Units
Oral Jelly60 Million Units
Creams/Ointments40 Million Units
Effervescent Tablets20 Million Units
Dry Powders/Granules3,600 KG

Quality & Compliance

Taj Medico follows strict international manufacturing standards:

  • WHO-GMP Certified Facility
  • EU GMP Expansion Program
  • PIC/S Compliance Development
  • ISO 9001:2018 Standards
  • ICH Guidelines
  • Validated HVAC Systems
  • Stability Chambers
  • In-house Quality Control Labs
  • Regulatory Documentation Support

EU Ready Dossiers Product List

MoleculeStrengthDosage FormTherapeutic AreaDossier StatusMA Status
Acebutolol200mg, 400mgTabletsAntihypertensiveAvailableApproved (France)
Aciclovir200mgTabletsAntiviralAvailableApproved (France & Spain)
Alfuzosin10mgTabletsBPHAvailableApproved (France & Spain)
Almotriptan12.5mgTabletsAnti-MigraineAvailableApproved (France & Spain)
Amlodipine5mg, 10mgCapsulesCardiovascularAvailableApproved (France & Spain)
Anastrozole1mgTabletsOncologyAvailableApproved (France & Spain)
Apixaban2.5mg, 5mgTabletsAnticoagulantAvailableApproved (France, Spain, Germany)
Aripiprazole5mg, 10mg, 15mgTabletsCNSAvailableApproved (France & Spain)
Atenolol50mg, 100mgTabletsCardiovascularAvailableApproved (France & Spain)
Atorvastatin10mg, 20mg, 40mg, 80mgTabletsCholesterol ManagementAvailableApproved (France & Spain)
Azithromycin250mgTabletsAntibioticAvailableApproved (France)
Baclofen10mgTabletsMuscle RelaxantAvailableUnder Approval
Betahistine8mg, 24mgTabletsVertigoAvailableApproved (France & Spain)
Bicalutamide50mgTabletsOncologyAvailableApproved (France & Spain)
Bisoprolol1.25mg, 2.5mg, 5mgTabletsCardiovascularAvailableUnder Approval
Bortezomib3.5mg/VialInjectionOncologyAvailableApproved (France, Spain, Germany)
Celecoxib100mg, 200mgCapsulesPain ManagementAvailableApproved (France & Spain)
Ciprofloxacin250mg, 500mgTabletsAntibioticAvailableApproved (France & Spain)
Clopidogrel75mgTabletsAntiplateletAvailableApproved (France & Spain)
Donepezil5mg, 10mgTablets/ODTNeurologyAvailableApproved (France & Spain)
Duloxetine30mg, 60mgCapsulesAntidepressantAvailableApproved (France & Spain)
Esomeprazole20mg, 40mgTabletsGastrointestinalAvailableApproved (France & Spain)
Etoricoxib30mg, 60mg, 90mg, 120mgTabletsPain ManagementAvailableApproved (France, Spain, Germany)
Fluconazole50mg–200mgCapsulesAntifungalAvailableApproved (France & Spain)
Gabapentin100mg–800mgCapsules/TabletsNeurologyAvailableApproved (France, Spain, Germany)

Upcoming EU Dossiers

Taj Medico is continuously expanding its regulated market portfolio with new dossier development projects.

MoleculeStrengthDosage FormTherapeutic AreaExpected Timeline
Enalapril2.5mg–20mgTabletsCardiovascularQ2 2025
Eltrombopag25mg, 50mg, 75mgTabletsHematologyQ4 2024
Brivaracetam25mg–100mgTabletsNeurologyQ4 2024
Vortioxetine5mg, 10mgTabletsAntidepressantQ2 2025
Escitalopram ODT10mg–20mgODTPsychiatryQ4 2024
Trazodone100mgTabletsAntidepressantQ4 2024
Lisdexamfetamine30mg–70mgCapsulesCNS StimulantQ2 2025
Safinamide50mg, 100mgTabletsParkinson’s DiseaseQ3 2025
Teriflunomide14mgTabletsMultiple SclerosisQ1 2025
Dapagliflozin + MetforminVarious StrengthsTabletsAntidiabeticQ3 2025
Dutasteride + Tamsulosin0.5mg + 0.4mgCapsulesUrologyQ3 2024
Ivermectin3mgTabletsAntiparasiticQ2 2025
Apremilast30mgTabletsDermatologyQ3 2025
Tofacitinib5mg, 10mgTabletsRheumatologyQ1 2026
Prednisolone ODT20mgODTAnti-AllergyQ1 2026

Why Choose Taj Medico for EU Partnerships?

✔ Ready EU dossiers available
✔ Regulatory documentation support
✔ WHO-GMP manufacturing facility
✔ Growing EU compliance infrastructure
✔ Fast product registration assistance
✔ Contract manufacturing solutions
✔ Private label opportunities
✔ Competitive pricing
✔ Reliable global supply chain


Your Trusted Partner for Europe

Taj Medico continues expanding its European pharmaceutical presence by delivering high-quality generic medicines, regulatory-ready dossiers, and scalable manufacturing solutions for partners seeking long-term growth in regulated markets.